Learn About Neurofibromatosis Type 2 (NF2)

What is the definition of Neurofibromatosis Type 2 (NF2)?

Neurofibromatosis 2 (NF2) is a disorder in which tumors form on the nerves of the brain and spine (the central nervous system). It may be passed down (inherited) in families.

Although it has a similar name to neurofibromatosis type 1, it is a different and separate condition.

What are the alternative names for Neurofibromatosis Type 2 (NF2)?

NF2; Bilateral acoustic neurofibromatosis; Bilateral vestibular schwannomas; Central neurofibromatosis

What are the causes of Neurofibromatosis Type 2 (NF2)?

NF2 is caused by a change in the gene NF2. NF2 can be passed down through families in an autosomal dominant pattern. This means that if one parent has NF2, any child of that parent has a 50% chance of inheriting the condition. Once someone carries the genetic change, their children have a 50% chance of inheriting it.

Some cases of NF2 occur when the gene mutates on its own. This is called sporadic and is not inherited. Once someone carries the genetic change, their children have a 50% chance of inheriting it.

What are the symptoms of Neurofibromatosis Type 2 (NF2)?

Symptoms of NF2 include:

  • Balance problems
  • Cataracts at a young age
  • Changes in vision
  • Coffee-colored marks on the skin (café-au-lait), less common
  • Headaches
  • Hearing loss
  • Ringing and noises in the ears
  • Weakness of the face
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Neurofibromatosis Type 2 (NF2)?

Acoustic nerve tumors can be observed or treated with surgery or radiation.

People with this disorder may benefit from genetic counseling.

People with NF2 should be regularly evaluated with these tests:

  • MRI of the brain and spinal cord
  • Hearing and speech evaluation
  • Eye exam
Who are the top Neurofibromatosis Type 2 (NF2) Local Doctors?
3825 Edwards Rd Ste 300, 
Cincinnati, OH 
 (5.1 mi)
Languages Spoken:
English

Mario Zuccarello is a Neurosurgery provider in Cincinnati, Ohio. Dr. Zuccarello and is rated as an Advanced provider by MediFind in the treatment of Neurofibromatosis Type 2 (NF2). His top areas of expertise are Acoustic Neuroma, Schwannoma, Moyamoya Disease, Extracranial-Intracranial Bypass Surgery, and Cerebral Artery Bypass Surgery.

Mayfield Clinic Inc

3825 Edwards Rd, Suite 300, 
Cincinnati, OH 
 (5.1 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Vincent Dinapoli is a Neurosurgery provider in Cincinnati, Ohio. Dr. Dinapoli and is rated as an Experienced provider by MediFind in the treatment of Neurofibromatosis Type 2 (NF2). His top areas of expertise are Choroid Plexus Cyst, Familial Porencephaly, Arachnoid Cysts, Awake Craniotomy, and Cervical Disc Surgery. Dr. Dinapoli is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Pediatric Radiology | Radiology
Pediatric Radiology | Radiology

Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (8.1 mi)
Languages Spoken:
English

Blaise Jones is a Pediatric Radiologist and a Radiologist in Cincinnati, Ohio. Dr. Jones and is rated as an Experienced provider by MediFind in the treatment of Neurofibromatosis Type 2 (NF2). His top areas of expertise are Hydrocephalus, Neurofibromatosis, Malignant Peripheral Nerve Sheath Tumor, and Spinal Tumor.

What are the support groups for Neurofibromatosis Type 2 (NF2)?

More information and support for people with NF2 and their families can be found at:

  • Children's Tumor Foundation -- www.ctf.org
  • Neurofibromatosis Network -- www.nfnetwork.org
What are the latest Neurofibromatosis Type 2 (NF2) Clinical Trials?
A Prospective Natural History Study of Patients With Neurofibromatosis Type 2 (NF2).

Summary: Objective With this prospective natural history study on neurofibromatosis type 2 (NF2) study, we hope to understand the factors leading to tumor progression and neurological disease burden in NF2. Study Population A total of 269 participants, ages 8-75, with a clinical or genetic diagnosis of NF2 will participate in this study. Design Study participants will be evaluated with a thorough physical ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Prospective, Randomized, Placebo-Controlled Phase II Trial of Aspirin for Vestibular Schwannomas

Summary: This is a phase II prospective, randomized, double-blind, longitudinal study evaluating whether the administration of aspirin can delay or slow tumor growth and maintain or improve hearing in VS patients.

Who are the sources who wrote this article ?

Published Date: December 31, 2023
Published By: Anna C. Edens Hurst, MD, MS, Associate Professor in Medical Genetics, The University of Alabama at Birmingham, Birmingham, AL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Goldblum JR, Folpe AL, Weiss SW. Benign tumors of peripheral nerves. In: Goldblum JR, Folpe AL, Weiss SW, eds. Enzinger and Weiss's Soft Tissue Tumors. 7th ed. Philadelphia, PA: Elsevier; 2020:chap 26.

Safier RA, Cleves-Bayon C, Gaesser J.  Neurology. In: Zitelli BJ, McIntire SC, Nowalk AJ, Garrison J, eds. Zitelli and Davis' Atlas of Pediatric Physical Diagnosis. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 16.

Sahin M, Ullrich N, Srivastava S, Pinto AL. Neurocutaneous syndromes. In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 636.